Wednesday , January 17 2018
Home / Resources / Polls (page 12)


Novo’s Two New Insulins

Last Friday, the FDA -- after rejecting them once -- finally approved Novo's two new Insulins, Tresiba and Ryzodeg. (See article for details.) Do you feel comfortable in recommending either to your patients? Follow the link to respond.

Read More »